Pseudomyxoma peritonei: cytomorphologic findings and clinicopathologic correlates.

J Am Soc Cytopathol

Division of Cytopathology, Department of Pathology, The Johns Hopkins Medical Institutions, Rm PATH 406, 600 N. Wolfe Street, Baltimore, Maryland 21287. Electronic address:

Published: September 2015

AI Article Synopsis

Article Abstract

Introduction: To analyze the cytomorphology and clinical correlates of pseudomyxoma peritonei (PP), a frequently fatal pathological entity defined by gelatinous ascites caused by slow but relentless accumulation of mucin produced by neoplastic glandular epithelium.

Materials And Methods: A retrospective search of the electronic pathology data systems of three large tertiary care medical institutions revealed 41 cases from 32 patients with PP and corresponding abdominal fluid cytologic specimens. Cytologic material was available for review in 15 cases.

Results: The primary tumor site was appendix in 25 (78.1%) of the 32 patients, other regions of the gastrointestinal tract in 2 (6.3%) patients, and in 5 (15.6%) patients, the primary could not be entirely identified. Of the 41 cases, only 15 had available cytologic slides to review. Extracellular mucin was a constant feature in all 15 (100%) cases, being abundant in 13 cases and focal in 2 cases. Predominance of mucin-secreting neoplastic epithelial cells were observed in 10 (66.7%) and muciphages in 11 (73.4%) cases. Cytopathologic interpretations were consistent with the subsequent histopathologic diagnosis in 30 of 32 cases (93.8%). There were two false negative cases, both of which showed scant mucinous material on second review.

Conclusions: PP is uncommonly encountered in routine cytopathology practice. The common denominator is the presence of an often-abundant extracellular mucin. Epithelial (glandular) component is usually scant. An accurate diagnosis in a fluid specimen requires proper identification of free/extracellular mucin as well as distinguishing the often "benign-appearing" epithelial cells from reactive mesothelial cells and histiocytes.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jasc.2015.09.214DOI Listing

Publication Analysis

Top Keywords

pseudomyxoma peritonei
8
cases
8
extracellular mucin
8
epithelial cells
8
peritonei cytomorphologic
4
cytomorphologic findings
4
findings clinicopathologic
4
clinicopathologic correlates
4
correlates introduction
4
introduction analyze
4

Similar Publications

Histologic grade is a key predictor for pseudomyxoma peritonei (PMP) of appendiceal origin that is used to guide clinical management. However, some tumors demonstrate disease behavior that deviates from their histologic grade. A recent study suggested that TP53, GNAS, and RAS mutation analysis could stratify tumors into distinct molecular groups with different prognosis.

View Article and Find Full Text PDF

A low-grade appendiceal mucinous neoplasm (LAMN) is a rare condition, occurring in 0.08-4.1% of appendectomy cases.

View Article and Find Full Text PDF

The necessity of prophylactic cytoreductive surgery (PCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for low-grade appendiceal mucinous neoplasms (LAMN) after complete removal is still controversial. This study aims to determine the role of PCRS + HIPEC and identify optimal strategies for managing these patients. One hundred fifty-nine patients who sought medical advice at Aerospace Center Hospital were retrospectively analyzed from January 2011 to December 2021.

View Article and Find Full Text PDF

Pleural extension of pseudomyxoma peritonei is rare, and treatment demands multidisciplinary care. Perioperative management during cytoreductive surgery and hyperthermic intrathoracic chemotherapy challenges anesthesiology and surgical teams in unique ways. Hemodynamic, arrhythmogenic, ventilatory, fluid balance, acid-base, and nephroprotection issues are important considerations.

View Article and Find Full Text PDF

Advances in cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) and pressurized intraperitoneal aerosol chemotherapy (PIPAC) have improved outcomes for selected patients with peritoneal surface malignancies (PSMs). This retrospective study analyzed 743 PSM patients treated at Fondazione Policlinico Universitario Agostino Gemelli from January 2016 to February 2024. The primary aim was to assess median overall survival (mOS), median disease-free survival (mDFS), and median progression-free survival (mPFS) stratified by tumor origin.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!